These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amorphous solid dispersions: a robust platform to address bioavailability challenges. Newman A, Nagapudi K, Wenslow R. Ther Deliv; 2015 Feb; 6(2):247-61. PubMed ID: 25690090 [Abstract] [Full Text] [Related]
3. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology. Tripathi D, B H MP, Sahoo J, Kumari J. Recent Adv Drug Deliv Formul; 2024 Feb; 18(2):79-99. PubMed ID: 38062659 [Abstract] [Full Text] [Related]
4. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions. Ricarte RG, Van Zee NJ, Li Z, Johnson LM, Lodge TP, Hillmyer MA. Mol Pharm; 2019 Oct 07; 16(10):4089-4103. PubMed ID: 31487183 [Abstract] [Full Text] [Related]
6. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study. Chavan RB, Lodagekar A, Yadav B, Shastri NR. Drug Deliv Transl Res; 2020 Aug 07; 10(4):903-918. PubMed ID: 32378174 [Abstract] [Full Text] [Related]
7. In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions. Mahmoudi ZN, Upadhye SB, Ferrizzi D, Rajabi-Siahboomi AR. AAPS J; 2014 Jul 07; 16(4):685-97. PubMed ID: 24789531 [Abstract] [Full Text] [Related]
15. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System. Baghel S, Cathcart H, O'Reilly NJ. Mol Pharm; 2018 Sep 04; 15(9):3796-3812. PubMed ID: 30020788 [Abstract] [Full Text] [Related]
16. Delivery of poorly soluble compounds by amorphous solid dispersions. Lee TW, Boersen NA, Hui HW, Chow SF, Wan KY, Chow AH. Curr Pharm Des; 2014 Sep 04; 20(3):303-24. PubMed ID: 23651395 [Abstract] [Full Text] [Related]
17. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug. Mitra A, Li L, Marsac P, Marks B, Liu Z, Brown C. Int J Pharm; 2016 May 30; 505(1-2):107-14. PubMed ID: 27012984 [Abstract] [Full Text] [Related]
19. Ternary solid dispersions: classification and formulation considerations. Borde S, Paul SK, Chauhan H. Drug Dev Ind Pharm; 2021 Jul 30; 47(7):1011-1028. PubMed ID: 33818224 [Abstract] [Full Text] [Related]
20. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties. Mann AKP, Schenck L, Koynov A, Rumondor ACF, Jin X, Marota M, Dalton C. J Pharm Sci; 2018 Jan 30; 107(1):183-191. PubMed ID: 28711592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]